Review Of The Drug Enforcement Administration's (DEA) Control Of The Diversion Of Controlled Pharmaceuticals
- NARA ID
- review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Source
- oig-doj
- Collection
- DOJ OIG — Other
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2002-09-01
- Slug
- doj-oig-review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Indexed
- 2026-04-27 05:13:58
More from DOJ OIG — Other
- Implementation of the Contractor Personnel Security Program in Selected Offices, Boards, and Divisions
- Review of the United States Marshals Service's Apprehension of Violent Fugitives
- Storey County Sheriff's Department, Nevada
- National Court-Appointed Special Advocate Program
- Audit of Department of Justice's Key Indicators
- U. S. Marshals Service Management of Aviation Operations
About the DOJ OIG — Other collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning this DOJ component.